glp-1 news september 2025 Pipeline Update: November - Prime Therapeutics fda glp-1 safety warning september

doi: 10.1089/jir.2014.0210 20 NorthR

Individuals taking magnesium supplements who experience persistent diarrhoea, unusual muscle weakness, or cardiac symptoms should discontinue supplementation immediately and seek medical advice

The company has completed its phase 1 clinical trial application with the Ministry of Food and Drug Safety in South Korea

Its inclusion in an injectable blend is based on the hypothesis that systemic delivery provides dermal-level ascorbic acid concentrations

Theyre generally most appropriate when theyre part of a medically guided plan that includes evaluation and monitoring, rather than being used as a standalone approach

doi: 10.1038/nature05484 9 FontaniniA